The adenosine A(2A) receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets

导出原文传递

翻译打印收藏纠错

作者： Uchida, Shin-ichi ^[1] ; Soshiroda, Kazuhiro ^[2] ; Okita, Eri ^[3] ; Kawai-Uchida, Mika ^[4] ; Mori, Akihisa ; Jenner, Peter ; Kanda, Tomoyuki

作者单位： Kings Coll London, Fac Life Sci & Med, Neurodegenerat Dis Res Grp, Inst Pharmaceut Sci, London SE1 ^[1] Kyowa Hakko Kirin Co Ltd, Cent Nervous Syst Res Labs, Cent Nervous Syst Res & Dev Unit, Div Res & ^[2] Kvowa Hakko Kirin Co Ltd, Res Core Funct Labs, Res Funct Unit, Div Res & Dev, Shizuoka 4118731 ^[3] Kyowa Hakko Kirin Co Ltd, Strateg Prod Portfolio Dept, Tokyo 1008185, Japan ^[4]

关键词 Anti-parkinsonian Adenosine A(2A) receptor antagonist L-DOPA Dopamine agonist MPTP

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

European Journal of Pharmacology

2015年766卷

25-30页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The adenosine A(2A) receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets

European Journal of Pharmacology

相似文献

European Journal of Pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The adenosine A(2A) receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets

European Journal of Pharmacology

相似文献

European Journal of Pharmacology

相关期刊

检索历史清除